Literature DB >> 31515676

Neuraminidase 1 regulates proliferation, apoptosis and the expression of Cadherins in mammary carcinoma cells.

Padmamalini Thulasiraman1, Kelbie Kerr2, Kathleen McAlister2, Samantha Hardisty2, Albany Wistner2, Ian McCullough2.   

Abstract

The link between Neuraminidase 1 (Neu1) and cancer development has been highlighted in numerous studies. In an effort to understand the role of Neu1 in mammary carcinoma cells, we evaluated the effect of Neu1 on controlling cell proliferation and apoptosis, as well as regulating the expression of cadherins. By blocking the activity of Neu1 with oseltamivir phosphate or using siRNA to silence the Neu1 protein, we observed suppression of cell growth in MCF-7 and MDA-MB-231 cells. Enhanced cleaved caspase 3 expression was demonstrated in breast cancer cells treated with oseltamivir phosphate or in Neu1 knockdown mammary carcinoma cells. We also provided evidence of Neu1 reversing the epithelial-mesenchymal properties with associated changes to the respective cadherin family. Additional observations indicated that the phytochemical, honokiol downregulates the expression of Neu1. As a consequence of blocking Neu1, honokiol reduced the levels of sialic acid in the two subtypes of breast cancer. These findings provide evidence that Neu1 regulates cell growth and death, and facilitates cancer progression by modulating the expression levels of cadherins.

Entities:  

Keywords:  Breast cancer; Cadherins; Honokiol; Neuraminidase 1

Mesh:

Substances:

Year:  2019        PMID: 31515676     DOI: 10.1007/s11010-019-03623-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

Review 1.  Mucins in cancer: protection and control of the cell surface.

Authors:  Michael A Hollingsworth; Benjamin J Swanson
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.

Authors:  Alanna M Gilmour; Samar Abdulkhalek; Timothy S W Cheng; Farah Alghamdi; Preethi Jayanth; Leah K O'Shea; Olivia Geen; Luis A Arvizu; Myron R Szewczuk
Journal:  Cell Signal       Date:  2013-08-30       Impact factor: 4.315

Review 3.  Sialic acids in cancer biology and immunity.

Authors:  Oliver M T Pearce; Heinz Läubli
Journal:  Glycobiology       Date:  2015-10-30       Impact factor: 4.313

4.  Effects of sialidase NEU1 siRNA on proliferation, apoptosis, and invasion in human ovarian cancer.

Authors:  Li-rong Ren; Li-ping Zhang; Shu-ying Huang; Yuan-fang Zhu; Wen-juan Li; Shan-yu Fang; Li Shen; Yan-ling Gao
Journal:  Mol Cell Biochem       Date:  2015-10-13       Impact factor: 3.396

Review 5.  Sialidases in vertebrates: a family of enzymes tailored for several cell functions.

Authors:  Eugenio Monti; Erik Bonten; Alessandra D'Azzo; Roberto Bresciani; Bruno Venerando; Giuseppe Borsani; Roland Schauer; Guido Tettamanti
Journal:  Adv Carbohydr Chem Biochem       Date:  2010       Impact factor: 12.200

6.  Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease.

Authors:  Alessandra d'Azzo; Erik Bonten
Journal:  Biochem Soc Trans       Date:  2010-12       Impact factor: 5.407

Review 7.  Sialic acids in human health and disease.

Authors:  Ajit Varki
Journal:  Trends Mol Med       Date:  2008-07-06       Impact factor: 11.951

8.  Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma.

Authors:  Guojun Hou; Gang Liu; Yuan Yang; Yixue Li; Shengxian Yuan; Linghao Zhao; Mengchao Wu; Lei Liu; Weiping Zhou
Journal:  Oncotarget       Date:  2016-10-04

9.  Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.

Authors:  Leah K O'Shea; Samar Abdulkhalek; Stephanie Allison; Ronald J Neufeld; Myron R Szewczuk
Journal:  Onco Targets Ther       Date:  2014-01-16       Impact factor: 4.147

10.  Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape.

Authors:  Christian Garbar; Corinne Mascaux; Yacine Merrouche; Armand Bensussan
Journal:  Cancer Manag Res       Date:  2018-05-04       Impact factor: 3.989

View more
  5 in total

Review 1.  Transmembrane Peptides as Inhibitors of Protein-Protein Interactions: An Efficient Strategy to Target Cancer Cells?

Authors:  Camille Albrecht; Aline Appert-Collin; Dominique Bagnard; Sébastien Blaise; Béatrice Romier-Crouzet; Roman G Efremov; Hervé Sartelet; Laurent Duca; Pascal Maurice; Amar Bennasroune
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

2.  Identification and Evaluation of New Potential Inhibitors of Human Neuraminidase 1 Extracted from Olyra latifolia L.: A Preliminary Study.

Authors:  Camille Albrecht; Zachée Louis Evariste Akissi; Philomène Akoua Yao-Kouassi; Abdulmagid Alabdul Magid; Pascal Maurice; Laurent Duca; Laurence Voutquenne-Nazabadioko; Amar Bennasroune
Journal:  Biomedicines       Date:  2021-04-11

3.  Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond.

Authors:  Erik P Lillehoj; Irina G Luzina; Sergei P Atamas
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 4.  Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases.

Authors:  Kévin Toussaint; Aline Appert-Collin; Hamid Morjani; Camille Albrecht; Hervé Sartelet; Béatrice Romier-Crouzet; Pascal Maurice; Laurent Duca; Sébastien Blaise; Amar Bennasroune
Journal:  Cancers (Basel)       Date:  2022-10-05       Impact factor: 6.575

5.  Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis.

Authors:  Intan M W Dewi; Cristina Cunha; Martin Jaeger; Mark S Gresnigt; Marina E Gkountzinopoulou; Fadel M Garishah; Cláudio Duarte-Oliveira; Cláudia F Campos; Lore Vanderbeke; Agustin Resendiz Sharpe; Roger J Brüggemann; Paul E Verweij; Katrien Lagrou; Greetje Vande Velde; Quirijn de Mast; Leo A B Joosten; Mihai G Netea; Andre J A M van der Ven; Joost Wauters; Agostinho Carvalho; Frank L van de Veerdonk
Journal:  Cell Rep Med       Date:  2021-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.